VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

The Indonesian Red Cross for Jakarta region (PMI Jakarta) expressed willingness, to collect blood of recovered COVID-19 patients, for trial of treatment using convalescent blood plasma, as proposed in Indonesia by Eijkman Molecular Biology Institute

As quoted by Antara News Agency, Salimar Salim, head of the transfusions unit at PMI Jakarta, expounded on Friday, that his side is ready to collect the blood plasma, yet PMI is currently awaiting official guidelines, apart from a minimum requirement of two weeks, after their symptoms resolve and only if they then test negative for COVID-19.

Salim revealed that the organization was currently also forging cooperation with the hospitals, since they have the data of patients that had recovered from the disease.

PMI Jakarta owns some seven blood plasma collection devices, of which three can be utilized for this plan, as well as the facilities to separate plasma from blood using the plasmapheresis method//Ant